Frederic Davesne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Frederic Davesne has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Florian Maronnat
IBISC Laboratory, Université Évry Paris Saclay, Évry, France
2 shared publications - Guillaume Loup
IBISC Lab, Universit Evry Paris-Saclay, France
2 shared publications - Samir Otmane
IBISC Lab, Univ Evry, Université Paris-Saclay
2 shared publications - Fadi Badra
Sorbonne Université, UMR_S 1142, LIMICS, Paris, France
1 shared publication Jonathan Degand
Univ Évry, IBISC, Université Paris-Saclay, Évry-Courcouronnes, France
1 shared publication- Joël Belmin
Hôpital Charles-Foix, Service de Court Séjour Gériatrique , Ivry-sur-Seine, Île-de-France
1 shared publication
Latest Publications
- Open Access
- 15 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Digital Tablet-Based Testings for the Screening of Neurocognitive Disorders in Older Adults: a Diagnosis Study. (Preprint)
BACKGROUND The prevalence of neurocognitive disorders (NCD) is increasing as the population ages. The diagnosis includes a time-consuming medical and neuropsychological battery of tests in specialized centers. The development of effective screening tools could benefit primary care professionals by improving referral practices. OBJECTIVE To explore the feasibility of a digital tablet-based investigation comprising a wide set of questions combined with cognitive and manual dexterity tasks, study their relevance for the diagnosis of NCD, and select the best combination of variables likely to help the screening. METHODS We conducted a prospective diagnosis study conducted in 2 memory clinics. We recruited older adults who underwent a comprehensive cognitive assessment with a specialized team leading to a reference diagnostic. This consisted in 3-category classification: no NCD, mild NCD (m-NCD) and major NCD (M-NCD). At the same time, they completed a variety of testings implemented on a touchscreen tablet which included a medical questionnaire, cognitive and manual dexterity tasks. We analyzed the dataset using several approaches to determine the most important variables for identifying M-NCD, or any NCD (either m-NCD or M-NCD). RESULTS We included 160 participants whose reference diagnosis were M-NCD for 58 of them, m-NCD for 52, and no NCD for 50. The feasibility of the index test battery was excellent; all participants answered the medical questionnaire, all completed the cognitive tasks, and there were 7 protocol stops during the manual dexterity tasks due to pain and poor hand detection. We achieved a final model with 9 variables for the detection of M-NCD and 5 for any NCD. The variables relevant for identifying M-NCD are those related to loss of independence, frailty, information processing, sleep, and executive functions related to manual dexterity (inhibition and mental flexibility). Sensitivity was 81% and specificity 86%, with an AUC of 0.90 for the screening of M-NCD. The variables relevant to identifying NCD are memory, categorization, processing speed, the presence of hypertension, and success in a motor task requiring mental flexibility. Sensitivity was 81% and specificity 82% with and AUC of 0.91 for the detection of any NCD. CONCLUSIONS We identified 2 combinations of variables that can distinguish any NCD from M-NCD with satisfactory performance for a screening. CLINICALTRIAL This study has been registered in clinical trial under the number NCT06032611. The protocol has been approved by the French national ethic committee (Comité de Protection des Personnes Est III) under the number IDRCB2022-A00609-34.
- 15 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDigital Tablet-Based Testings for the Screening of Neurocognitive Disorders in Older Adults: a Diagnosis Study. (Preprint)
BACKGROUND The prevalence of neurocognitive disorders (NCD) is increasing as the population ages. The diagnosis includes a time-consuming medical and neuropsychological battery of tests in specialized centers. The development of effective screening tools could benefit primary care professionals by improving referral practices. OBJECTIVE To explore the feasibility of a digital tablet-based investigation comprising a wide set of questions combined with cognitive and manual dexterity tasks, study their relevance for the diagnosis of NCD, and select the best combination of variables likely to help the screening. METHODS We conducted a prospective diagnosis study conducted in 2 memory clinics. We recruited older adults who underwent a comprehensive cognitive assessment with a specialized team leading to a reference diagnostic. This consisted in 3-category classification: no NCD, mild NCD (m-NCD) and major NCD (M-NCD). At the same time, they completed a variety of testings implemented on a touchscreen tablet which included a medical questionnaire, cognitive and manual dexterity tasks. We analyzed the dataset using several approaches to determine the most important variables for identifying M-NCD, or any NCD (either m-NCD or M-NCD). RESULTS We included 160 participants whose reference diagnosis were M-NCD for 58 of them, m-NCD for 52, and no NCD for 50. The feasibility of the index test battery was excellent; all participants answered the medical questionnaire, all completed the cognitive tasks, and there were 7 protocol stops during the manual dexterity tasks due to pain and poor hand detection. We achieved a final model with 9 variables for the detection of M-NCD and 5 for any NCD. The variables relevant for identifying M-NCD are those related to loss of independence, frailty, information processing, sleep, and executive functions related to manual dexterity (inhibition and mental flexibility). Sensitivity was 81% and specificity 86%, with an AUC of 0.90 for the screening of M-NCD. The variables relevant to identifying NCD are memory, categorization, processing speed, the presence of hypertension, and success in a motor task requiring mental flexibility. Sensitivity was 81% and specificity 82% with and AUC of 0.91 for the detection of any NCD. CONCLUSIONS We identified 2 combinations of variables that can distinguish any NCD from M-NCD with satisfactory performance for a screening. CLINICALTRIAL This study has been registered in clinical trial under the number NCT06032611. The protocol has been approved by the French national ethic committee (Comité de Protection des Personnes Est III) under the number IDRCB2022-A00609-34.
- Open Access
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Conception and usability pilot study of a new digital cognitive screening tool on tablet: AlzVR project
Introduction: Alzheimer's disease (AD) is the first cause of dementia worldwide without any current curative treatment. Facing an increasing prevalence and its associated costs, AD represents a public health challenge. Usual diagnostic methods still rely on extended interviews and paper tests provided by an exterior examiner. We aim to create a novel, quick cognitive-screening tool on a numerical tablet. Methods: This pilot program, built and edited with Unity ® , runs on Android ® for the Samsung Galaxy Tab S7 FE ® . Composed of seven tasks inspired by the Mini-Mental Status Examination and the Montréal Cognitive Assessment, it browses several cognitive functions. The architectural design of this tablet application is distinguished by its multifaceted capabilities, encompassing not only seamless offline functionality but also a mechanism to ensure the singularity of data amalgamated from diverse sites. Additionally, a paramount emphasis is placed on safeguarding the confidentiality of patient information in the healthcare domain. Furthermore, the application empowers individual site managers to access and peruse specific datasets, enhancing their operational efficacy and decision-making processes. We performed a preliminary usability assessment among young, healthy subjects. Results: Twenty-four participants were included with a final F-SUS ‘excellent’ score. Participants perceived the tool as simple to use and achieved the test in a mean time of 142 s. No technical errors occurred. Conclusion: These preliminary results suggest that our new assessment on a numerical tablet might be usable and acceptable for a short cognitive screening but requires further studies among older populations.
- 1 May 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessConception and usability pilot study of a new digital cognitive screening tool on tablet: AlzVR project
Introduction: Alzheimer's disease (AD) is the first cause of dementia worldwide without any current curative treatment. Facing an increasing prevalence and its associated costs, AD represents a public health challenge. Usual diagnostic methods still rely on extended interviews and paper tests provided by an exterior examiner. We aim to create a novel, quick cognitive-screening tool on a numerical tablet. Methods: This pilot program, built and edited with Unity ® , runs on Android ® for the Samsung Galaxy Tab S7 FE ® . Composed of seven tasks inspired by the Mini-Mental Status Examination and the Montréal Cognitive Assessment, it browses several cognitive functions. The architectural design of this tablet application is distinguished by its multifaceted capabilities, encompassing not only seamless offline functionality but also a mechanism to ensure the singularity of data amalgamated from diverse sites. Additionally, a paramount emphasis is placed on safeguarding the confidentiality of patient information in the healthcare domain. Furthermore, the application empowers individual site managers to access and peruse specific datasets, enhancing their operational efficacy and decision-making processes. We performed a preliminary usability assessment among young, healthy subjects. Results: Twenty-four participants were included with a final F-SUS ‘excellent’ score. Participants perceived the tool as simple to use and achieved the test in a mean time of 142 s. No technical errors occurred. Conclusion: These preliminary results suggest that our new assessment on a numerical tablet might be usable and acceptable for a short cognitive screening but requires further studies among older populations.